Josh Waizer is a healthcare and antitrust expert specializing in data-driven solutions for payor-provider disputes, reimbursement, managed care, and competition challenges.
Josh Waizer has more than a decade of experience providing economic analysis to clients including health plans, providers, pharmaceutical manufacturers, and government agencies. He helps clients navigate litigation, assess risk and exposure, and develop actionable insights and solutions to tackle healthcare and policy issues. He excels at distilling intricate economic concepts into clear, accessible explanations that resonate with judges, juries, and decision-makers. His collaborative approach enables him to deeply understand the legal, business, and economic issues at play, equipping him to translate complex data into compelling narratives and persuasive testimony.
His experience spans the healthcare, pharmaceutical, and big tech industries and his expertise includes antitrust litigation and merger reviews, causation and damages assessments, class certification analysis, and preparing responses for government investigations. He has submitted expert reports analyzing healthcare data and calculating market shares. He has successfully led teams in high stakes matters involving mergers, monopolization, monopsony, class certification, and damages. Notable cases include In re National Prescription Opiate Litigation, In re WellPoint, Inc. Out-of-Network “UCR” Rates Litigation, United States v. Google, LLC, and Epic Games Inc. v. Google.
He also co-leads the firm’s Consultant Development Program, which provides mentoring and professional development to help early-career employees. He provides guidance to early career consultants and their managers, evaluates consultants’ progress and development needs, and ensures they have opportunities to grow their careers and develop well-rounded skills.
Education
BA, Economics (with honors), Brandeis University
BA, Politics, Brandeis University
